Purchase this article with an account.
Scott Gardner, Bingjie Ling, Bruce E. Prum, Jr., Sandra M. Johnson; A Retrospective Review Of 384 Baerveldt 350 mm2 Glaucoma Implants With Scleral Patch Graft: Results And Complications. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3715.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the long-term outcomes and complications of Baerveldt 350 mm2 glaucoma implants with scleral patch graft.
In this retrospective, non-comparative case series, 510 implants were placed in 490 eyes between 1995 and 2011. 384 surgeries met criteria for inclusion (minimum age of 18 with at least 6 months follow-up). All implants were placed by a single surgeon (BEP) and included an eye bank scleral patch graft. Data extracted included patient demographics, past medical history, ocular history, pre- and postoperative vision and intraocular pressure (IOP), glaucoma type, location of implant, and postoperative complications at years 1, 2, 3, 5, 10, and 15.
The rate of long-term postoperative tube/plate exposure was low, and all occurred within the first three years and were easily managed. Corneal edema was a common long-term complication, and the incidence increased with time. Subsequent surgery due to a complication was necessary most frequently during the first and tenth postoperative years. A Baerveldt 350 mm2 glaucoma implant with a scleral patch graft is an effective intervention for long-term IOP control to supplement the medical treatment of refractory glaucoma. Complete statistical analysis will be presented.
This PDF is available to Subscribers Only